Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
Arthritis and Rheumatism
|
November 9, 2012
Vitamin D, race, and experimental pain sensitivity in older adults with knee osteoarthritis
T L Glover, B R Goodin, A L Horgas, et al.
Osteoarthritis and Cartilage
|
August 27, 2013
Experimental pain sensitivity differs as a function of clinical pain severity in symptomatic knee osteoarthritis
C D King, K T Sibille, B R Goodin, et al.
Clinical Pharmacology and Therapeutics
|
February 26, 2010
Pharmacodynamics and pharmacokinetics of AM103, a novel inhibitor of 5-lipoxygenase-activating protein (FLAP)
G Bain, C D King, M Rewolinski, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 17, 2010
Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist
J S Swaney, C Chapman, L D Correa, et al.
Biorxiv : the Preprint Server for Biology
|
July 18, 2023
β-hydroxybutyrate is a metabolic regulator of proteostasis in the aged and Alzheimer disease brain
S S Madhavan, S Roa Diaz, S Peralta, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
Arthritis and Rheumatism
|
November 9, 2012
Vitamin D, race, and experimental pain sensitivity in older adults with knee osteoarthritis
T L Glover, B R Goodin, A L Horgas, et al.
Osteoarthritis and Cartilage
|
August 27, 2013
Experimental pain sensitivity differs as a function of clinical pain severity in symptomatic knee osteoarthritis
C D King, K T Sibille, B R Goodin, et al.
Clinical Pharmacology and Therapeutics
|
February 26, 2010
Pharmacodynamics and pharmacokinetics of AM103, a novel inhibitor of 5-lipoxygenase-activating protein (FLAP)
G Bain, C D King, M Rewolinski, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 17, 2010
Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist
J S Swaney, C Chapman, L D Correa, et al.
Biorxiv : the Preprint Server for Biology
|
July 18, 2023
β-hydroxybutyrate is a metabolic regulator of proteostasis in the aged and Alzheimer disease brain
S S Madhavan, S Roa Diaz, S Peralta, et al.
Page
of 5